Population
Voltage-gated potassium channels KCNQ2-5 (specifically KCNQ3 and KCNQ5)
Design
Preclinical
Authors
Loading...
Cannot yet guide clinical decisions on metabolite therapies; leaves open direct KCNQ activation by GABA/BHB in human excitability disorders.
The study reveals a novel paradigm of direct neurotransmitter activation of voltage-gated ion channels, enabling chemosensing to regulate cellular excitability.
Manville et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: